guest ::
| Home > Publications database > Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations. > print |
| Home > Publications database > Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations. > print |
| 001 | 277948 | ||
| 005 | 20240229155029.0 | ||
| 024 | 7 | _ | |a 10.1016/j.exphem.2023.07.006 |2 doi |
| 024 | 7 | _ | |a pmid:37543237 |2 pmid |
| 024 | 7 | _ | |a 0531-5573 |2 ISSN |
| 024 | 7 | _ | |a 0301-472X |2 ISSN |
| 024 | 7 | _ | |a 1873-2399 |2 ISSN |
| 024 | 7 | _ | |a altmetric:153264152 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-01591 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Rubio-Lara, Juan A |b 0 |
| 245 | _ | _ | |a Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations. |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2023 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1695124785_15139 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A011#LA:A010# / Volumes 125–126, September–October 2023, Pages 6-15 / Perspective |
| 520 | _ | _ | |a Hematopoietic stem cells (HSCs) are the most primitive cell type in the hematopoietic hierarchy, which are responsible for sustaining the lifelong production of mature blood and immune cells. Due to their superior long-term regenerative capacity, HSC therapies such as stem cell transplantation have been used in a broad range of hematological disorders. However, the rarity of this population in vivo considerably limits its clinical applications and large-scale analyses such as screening and safety studies. Therefore, ex vivo culture methods that allow long-term expansion and maintenance of functional HSCs are instrumental to overcome difficulties in studying HSC biology and improving HSC therapies. In this perspective, we discuss recent advances and technical considerations for three ex vivo HSC expansion methods including 1) polyvinyl alcohol-based HSC expansion, 2) mesenchymal stromal cell-HSC co-culture, and 3) 2D/3D hydrogel HSC culture. This review summarizes the presentations and discussions from the 2022 International Society for Experimental Hematology (ISEH) Annual Meeting New Investigator Technology Session. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Igarashi, Kyomi J |b 1 |
| 700 | 1 | _ | |a Sood, Shubhankar |0 P:(DE-He78)dbe2fd9578ec0bf59e0e17592b04f22f |b 2 |e First author |u dkfz |
| 700 | 1 | _ | |a Johansson, Alban |b 3 |
| 700 | 1 | _ | |a Sommerkamp, Pia |b 4 |
| 700 | 1 | _ | |a Yamashita, Masayuki |b 5 |
| 700 | 1 | _ | |a Lin, Dawn S |0 P:(DE-HGF)0 |b 6 |e Last author |
| 773 | _ | _ | |a 10.1016/j.exphem.2023.07.006 |g p. S0301472X23016673 |0 PERI:(DE-600)2005403-8 |n September–October |p 6-11 |t Experimental hematology |v 125–126 |y 2023 |x 0531-5573 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:277948 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)dbe2fd9578ec0bf59e0e17592b04f22f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-08 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-08 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-23 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EXP HEMATOL : 2022 |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-23 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-23 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-23 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-08-23 |
| 920 | 2 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A011-20160331 |k A011 |l A011 Stressinduzierte Aktivierung von Hämatopeotischen Stammzellen |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 1 |
| 920 | 0 | _ | |0 I:(DE-He78)A011-20160331 |k A011 |l A011 Stressinduzierte Aktivierung von Hämatopeotischen Stammzellen |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A011-20160331 |
| 980 | _ | _ | |a I:(DE-He78)A010-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|